Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations

Diabetologia

Volumn 44, Issue 2, 2001, Pages 249-258

  Weng, J ^a   Macfarlane, W M ^b   Lehto, M ^a   Gu, H F ^a   Shepherd, L M ^b   Ivarsson, S A ^a   Wibell, L ^c   Smith, T ^d   Groop, L C ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d Simrishamn Hospital   (Sweden)

Author keywords

Gene expression; Insulin gene; Insulin promoter factor 1; Maturity onset diabetes of the young (MODY); Type II diabetes

Indexed keywords

ADULT; ALLELISM; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; HUMAN; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

EID: 0035137251     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051608     Document Type: Article

References (24)

1. Heterogeneity in Type II diabetes: Lessons from maturity-onset diabetes of the young
2. Mutation in hepatocyte nuclear factor-1 gene (TCF2) associated with MODY
3. High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes
4. Hepatocyte nuclear factor-1β (MODY5) gene mutations in Scandinavian families with early-onset diabetes or kidney disease or both
5. Isolation, characterisation, and chromosomal mapping of the human insulin promoter factor 1 (IPF-1) gene
6. IPF1, a homeodomain-containing transactivator of insulin gene
7. Insulin-promoter-factor 1 is required for pancreas development in mice
8. Early-onset diabetes mellitus (MODY4) linked to IPF 1
9. Missence mutations in the insulin promoter factor-1 gene predispose to Type II diabetes
10. Defective mutations in the insulin promoter factor-1 (IPF1) gene in late-onset Type II diabetes mellitus
11. Metabolic consequences of a family history of NIDDM (The Botnia Study)
12. Engineering a glucose-responsive human insulin secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinaemic hypoglycaemia of infancy
13. Glucose modulates the binding activity of the β-cell transcription factor IUF1 in a phosphorylation-dependent manner
14. A vector for expressing GAL4(1-147) fusions in mammalian cells
15. 2+
16. Functional regions of the homeodomain protein IDX-1 required for transactivation of the rat somatostatin gene
17. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset Type II diabetes mellitus in Caucasians
18. Early-onset type II diabetes mellitus (MODY4) linked to IPF-1
19. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum
20. Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1
21. Functional characterization of the transactivation properties of the PDX-1 homeodomain protein
22. Regulatory factor linked to late-onset diabetes?
23. Insulin promoter factor-1 gene mutation linked to early-onset Type II diabetes mellitus directs expression of a dominant negative isoprotein
24. Mutations in the HNF4α gene affect insulin secretion and triglycerine metabolism